Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
YEAH BETTER THEN EXPECTED IMHO ..
what huge news? That they were able to turn a profit in the last twelve months?
I THINK SO ..HUGE NEWS
Mark Libratore grew Polymedica into a multi million company in the 90's....will he do the same with similar business here?
Decent recovery lately.
Looks like others have been concerned about SOMETHING over the past two months.
Basically, I am seeing a very large jump in "deferred advertising" in the cash flow statement over the last 6 months.
I am wondering if it is a cause for concern longer term. I am looking for someone who may have done some analysis on this.
Not my area of expertise -- maybe one of the other board denizens will chime in....
LBMH advertising+link to write-up on LBMH
I have a question.
How do you determine advertising costs in terms of acquisition costs per customer. I can see advertising expenditure is rising, but this is okay if the cost to acquire each new customer [per customer] is not dramatically increasing.
Anyone understand how to estimate this based on revenue trends and the accounting treatment of their advertising expenditure [They capitalize advertising rather than expense it]
LBMH write-up [not mine]
http://seekingalpha.com/instablog/189276-frank-lind/176340-value-investor-club-write-up-on-liberator-medical
Interesting. I knew it was cycling in that general range but didn't actually get around to drawing the channels.
Great looking channel, looking for a break of 1.50. Set those alerts!!
http://onlycharts.com
Yes- They update on most picks monthly. Probably the best $60 a year I spend, lol.
Does Bowser do follow-ups on prior picks?
fwiw, I took a small position in April based on the Bowser report. Looking for my double
Pretty quiet here. You guys still around?
Aha, that explains it. Thanks for solving the mystery.
Bowser Report Co. of the Month for April helped the volume soar along with the stock price on Monday. Appears to be a very well run company with solid continued growth potential
..................108,000 traded so far up + .15.Patience is a virtue in this market.This will be a money maker to those that wait..........
LBMH had been creeping up for awhile on low volume. Now will it retrace further or bounce off 1.35-1.40?
Nice write up about the company. Everything in the company is still going strong besides the share price. We have to get off the otcbb this year, that will help a lot. I did sell some shares though 5000 for the purchase of a home but still holding 43000.
With only 48 million shares O/S, I doubt we will see much liquidity...
Nice effort.
I wonder what can be done to increase liquidity. If nothing else, if a fund starts buying up the stock and the price goes into the $3-4 range, some sellers will come out and volume will increase.
I did a write up on LBMH and there will be more coming. Trying to help get this company discovered as it is way off the radar.
http://tradelibrary.wordpress.com/2011/02/17/lbmh-liberator-medical-holdings-inc-otcbb/
Thanks,
Trade
Dunno. This is one that I just put away and don't pay attention to. I just think it'll have a run eventually. I've never even spoken with management.
Has anyone contacted the company recently? I know there numbers were due December 29th but they filed for an extension. The only reason for this imo would be the fact that they got a new auditing firm. Since it was year end I'm sure it took longer to get things in order. Hopefully the number will still show signs of growth.
Wow, a month with no posts. The chart seems to be turning up lately so maybe people will begin waking up.
Interesting information....
December 02, 2010 1:29 AM ETCONSUMER STAPLES SECTOR | FOOD & STAPLES RETAILING INDUSTRYLIBERATOR MEDICAL HOLDINGS I
(LBMH:OTC BB)
LAST $1.41 USDCHANGE TODAY +0.05 3.68%VOLUME 19.7KLBMH On Other ExchangesAs of 8:10 PM 12/1/10 All times are local (Market data is delayed by at least 15 minutes).
SnapshotNewsChartsFinancialsEarningsPeopleOwnershipTransactionsOptions
OverviewBoard MembersCommittees EXECUTIVE PROFILE*
Mark Libratore Return to LIBERTY HOLDINGS LTD
Chairman, Chief Executive Officer, President and Secretary, Liberator Medical Holdings, Inc.
44
Age Total Annual Compensation This person is connected to 4 board members in 1 different organizations across 2 different industries.
See Board Relationships
58 $318,070 USD
As of Fiscal Year 2009
BACKGROUND*
Mark A. Libratore serves as the Chief Executive Officer, President and Secretary of Liberator Medical Holdings Inc. Mr. Libratore founded Liberator Medical Supply Inc., in 1999 and serves as its President and Chief Executive Officer. In 1990, he founded Liberty Medical Supply Inc., which has become the nation's largest direct-to-consumer diabetic supplier. Mr. Libratore sold this business to PolyMedica Corporation (PLMD) in August 1996 and remained President of Liberty ... Medical and Vice President of PolyMedica until February 1999. Mr. Libratore founded Liberty Medical Supply, Inc. In 1990 and served as its President until February 1999. He served as the President of Family Healthcare Solutions Inc. He served as Vice President of PolyMedica Corporation until February 1999. He has been a Director of Liberator Medical Holdings, Inc. since 2007. The April 1998 issue of Response Magazine voted Mr. Libratore one of the top 25 most innovative direct TV advertisers of the year.
Collapse Detail
CORPORATE HEADQUARTERS*
2979 SE Gran Park Way
Stuart, Florida 34997
United States
Phone: 772-287-2414
Fax: 772-286-7881
Board Members MEMBERSHIPS*
2007-Present
Chairman, Chief Executive Officer, President and Secretary
Liberator Medical Holdings, Inc.
EDUCATION*
There is no Education data available.
OTHER AFFILIATIONS*
Family Healthcare Solutions Inc.,
Liberator Medical Holdings, Inc., Prior to Reverse Merger with Liberator Medical Supply, Inc.
Liberator Medical Supply, Inc. ANNUAL COMPENSATION*
Salary $230,000
Bonus $88,070
Total Annual Compensation $318,070
STOCK OPTIONS*
All Other Compensation $43,090
Exercisable Options 100,000
Unexercisable Options 90,000
Total Number of Options 190,000
TOTAL COMPENSATION*
Total Annual Cash Compensation $318,070
Total Short Term Compensation $318,070
Other Long Term Compensation $43,090
Total Calculated Compensation $363,970
*Data is at least as current as the most recent Definitive Proxy.
Hosting an End of the Year conference call with Mark would be helpful to the investors to give some presence and start building a foundation with investors.
Last year Annual Report was released Friday December 18th. Keep your eyes out for it, it should be a good read.
Not without a much higher stock price, so it's not happening anytime soon.
They are sitting on a remarkable $6 or $7 million cash so no fear of dilution in the forseeable future. I see their adds constantly in New York. They are rapidly growing.
I agree, and to clarify my prior post -- they have obviously decided that it will be most advantageous to "get big fast," and I didn't mean to imply that that's a bad decision even though EPS may suffer in the short term.
Yes I agree. He has also hired 75 people to grow his sales calling center. Mark is also hiring a Call Center Manager to overlook 160 Sales seats. The company is growing and that is the bottom line. The net income may not be as attractive this quarter because of the training costs. This may offset that though which I'm sure many investors have forgot about.
Liberator will receive approximately $134,000 to help train the 200 new, permanent, full-time employees it plans to hire during the next 24 months.
Read Article:
http://www.marketwire.com/press-release/Business-Development-Board-Martin-County-Helps-Solidify-Liberator-Medical-Supplys-Expansion-969826.htm/
2011 should be a very strong year as to where I see this company growing in the future.
Yes, a very enthusiastic press release. However, it's always a yellow flag for me when a company trumpets increases in gross revenues, or other things like "net revenues" or "gross profit" or even EBITDA, and doesn't mention net income. Let's see what the 10-Q says.
This company just keeps reporting incredible revenue increases quarter after quarter...........
Liberator Medical Reports Record Net Revenues for Its Fourth Fiscal Quarter and Full Year Ended September 30, 2010 and Adds a New Board Member
0 minutes ago - Globenewswire
Related Companies
Symbol Last %Chg
LBMH 1.35 0.00%
As of 3:50 PM ET 11/18/10
Liberator Medical Holdings, Inc. (OTCBB:LBMH) today announced record net revenues of approximately $11.49 million for its fiscal fourth quarter ended September 30, 2010, and $40.92 million for the fiscal year ended September 30, 2010.
Net revenues for the fourth fiscal quarter 2010 increased 51.5% from $7.586 million for the quarter ended September 30, 2009, and up 8.2% sequentially from $10.62 million for the quarter ended June 30, 2010. For fiscal year 2010, the Company reported net revenues of $40.92 million, representing an increase of 58.5% over fiscal year 2009 net revenues of $25.82 million.
Mark Libratore, the Company's President and CEO, commented, "Despite difficult advertising conditions due to the aggressive election spending on direct response time slots, this is the tenth consecutive quarter we have reported record net revenues. I am also very pleased that we have achieved our internal revenue growth objective of increasing net revenue for fiscal year ended 2010 by 50% over fiscal year ended 2009. Liberator's substantial sales growth is a result of our continued commitment to our direct marketing efforts and dedication to customer service. In addition, we are starting to see the benefits from the completion of our new facility and our 75 new employees. During the last quarter of the calendar year, we expect our strong sales trends to continue driven by proven advertising methods and additional staff members."
Appointment of new Board Member
On October 21, 2010, the Company announced the appointment of Tyler Wick to the Board of Directors. Mr. Wick co-founded Ticonderoga Capital and has over thirteen years of industry tenure in the financial markets including eleven years of private equity experience. His private equity experience includes serving as an Associate at Dillon Read Venture Capital and ten years at Ticonderoga Capital. Previously, Mr. Wick was an Associate in the healthcare practice of the investment-banking group of Advest, Inc., where he focused on private placements and mergers and acquisitions for middle market healthcare services companies.
Prior to Advest, Mr. Wick was a consultant with the Mentor Group, an international legal consulting firm. Mr. Wick is a member of the Board of Directors of AFS Technologies, ALN Medical Management, Brainshark, Octagon Research, Outside the Classroom and Softrax and is an Observer to the Boards of nuBridges and Construction Software Technologies. He is also a member of the Executive Committee of NERASBIC and serves on the Board of Directors of the Boston Chapter of the Association for Corporate Growth. Mr. Wick received a B.A. degree cum laude from Amherst College.
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider(TM) accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes supplies, catheters, ostomy supplies and mastectomy fashions . Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
Certain statements in this press release that are not historical, but are forward-looking, are subject to known and unknown risks and uncertainties which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, the risk of early obsolescence of our products and the other factors listed under "Risks and Uncertainties" in our annual report on Form 10-K for the fiscal year ended September 30, 2009, and our other filings with the Securities and Exchange Commission. We assume no obligation to update the information contained in this news release.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Liberator Medical Holdings, Inc.
CONTACT: Wall Street Resources, Inc.
Individual Investor Relations Contact:
Gerald Kieft
772-219-7525
LiberatorIR@wallstreetresources.net
http://www.wallstreetresources.net
Littlebanc Advisors, LLC
Institutional Investor Contact:
Lyn Davis
561-948-3005
ld@littlebanc.com
www.littlebanc.com
I don't have time to mess with IBoxes, but congrats! You're now an Assistant Mod, so feel free to take a crack at it.
Can you please update this board. The CEO is Mark Libratore. When the boardmarks from 10 start increase because people start to discover this company It seems to be appropriate to update this message board. Thanks and I'm long on LBMH as I see this going much higher.
It looks to me like there are two ways to play LBMH in the short term: 1- buy near 1.20 support for a move to the 1.50 area, or 2- buy a break of 1.50 for a chance at 2.00+, with a stop loss if it falls back below 1.50.
Either way, holding the stock for the medium to long term seems like a decent idea, given management's track record.
Is this old news?
Liberator order for 15k devices pending full approval
http://investors.positiveidcorp.com/releasedetail.cfm?ReleaseID=520694
SITTING ON 6 - 7 MILLION CASH.
Net Revenues of $10.62 Million and Net Income of $798 Thousand for the Quarter Ended June 30, 2010
STUART, Fla., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Liberator Medical Holdings, Inc. (OTCBB:LBMH) today announces the financial results for its fiscal third quarter ended June 30, 2010, including record net revenue of $10.62 million and net income of $798 thousand.
Fiscal Third Quarter 2010 Highlights
•Net revenue for the third quarter ended June 30, 2010, was $10.62 million, an increase of 52.8% from $6.95 million for the quarter ended June 30, 2009.
•Gross profit for the third quarter ended June 30, 2010, was $6.94 million, an increase of 56.2% from $4.44 million for the quarter ended June 30, 2009.
•The Company's operating expenses for the three months ended June 30, 2010, were $6.0 million, or 56.5% of revenue, compared to $3.37 million, or 48.5%, of revenue for the three months ended June 30, 2009.
•Net income remained relatively flat at $798 thousand compared with $794 thousand for the quarter ended June 30, 2009.
•The Company had $6.889 million in cash as of June 30, 2010.
Mark Libratore, the Company's President and CEO, commented, "This is our 8th consecutive quarter of earnings and our 10th consecutive quarter of sales growth. Our additional staffing and infrastructure performed as expected. We still have ample excess capacity both in call-center and operational facilities. We believe that we are well positioned to continue to grow our sales and improve profitability over the long term."
Revenues:
Sales for the three months ended June 30, 2010, increased by $3,669,000, or 52.8%, to $10,619,000, compared with sales of $6,950,000 for the three months ended June 30, 2009. The increase was due to a substantial direct response advertising campaign to obtain new mail order customers. Sales for the nine months ended June 30, 2010, increased by $11,309,000, or 62.4%, to $29,428,000, compared with sales of $18,119,000 for the nine months ended June 30, 2009, as a result of the direct response advertising campaign.
Gross Profit:
Gross profit for the three months ended June 30, 2010, increased by $2,498,000, or 56.2%, to $6,942,000, compared with gross profit of $4,444,000 for the three months ended June 30, 2009. Gross profit for the nine months ended June 30, 2010, increased by $7,422,000, or 63.5%, to $19,116,000, compared to $11,694,000 for the nine months ended June 30, 2009. The increase was attributed to increased sales volume for the three and nine months ended June 30, 2010, compared to the three and nine months ended June 30, 2009. As a percentage of sales, the increases in gross profit for the three and nine months ended June 30, 2010 are primarily attributed to product mix and, to a lesser extent, a reduction in freight costs compared to the three and nine months ended June 30, 2009.
Operating Expenses:
Operating expenses for the three months ended June 30, 2010, were $6,000,000, or 56.5% of sales, compared with $3,372,000, or 48.5% of sales for the three months ended June 30, 2009. Operating expenses for the nine months ended June 30, 2010, were $16,655,000, or 56.6% of sales, compared with $9,750,000, or 53.8% of sales, for the nine months ended June 30, 2009. The increases in operating expenses are primarily attributed to increased spending levels for additional employees, advertising costs, rent, depreciation and other administration costs to support our current and future sales growth.
Other Income (Expense):
Other income (expense) is predominantly interest expense associated with our convertible debt, shareholder loans, and credit line facility. Interest expense decreased by $117,000 to $150,000 for the three months ended June 30, 2010, compared with $267,000 for the three months ended June 30, 2009. For the nine months ended June 30, 2010, interest expense decreased by $191,000 to $621,000, compared with $812,000 for the nine months ended June 30, 2009. The decreases are primarily attributed to a reduction in outstanding convertible notes payable and the associated interest expense.
Liquidity and Capital Resources
The Company had cash of $6,889,000 at June 30, 2010, compared to cash of $3,798,000 at September 30, 2009, an increase of $3,091,000. The increase in cash for the nine months ended June 30, 2010, is primarily attributed to the sale of common stock to a single institutional investor in March 2010 for gross proceeds of $7 million and proceeds from the exercise of warrants, partially offset by direct response advertising costs, the build out of our new 24,000 square foot facility, payments on our outstanding shareholder loan, and an increase in the level of operating assets over operating liabilities, primarily accounts receivable.
Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider(TM) accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes, urological, ostomy and mastectomy patients. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
Certain statements in this press release that are not historical, but are forward-looking, are subject to known and unknown risks and uncertainties which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, the risk of early obsolescence of our products and the other factors listed under "Risks and Uncertainties" in our annual report on Form 10-K for the fiscal year ended September 30, 2009, and our other filings with the Securities and Exchange Commission. We assume no obligation to update the information contained in this news release.
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands, except per share amounts)
June 30,
2010 Sept. 30,
2009
(unaudited)
Assets
Current Assets:
Cash $ 6,889 $ 3,798
Restricted cash 1,060 500
Accounts receivable, net of allowances of $3,622 and $2,327, respectively 6,511 3,850
Inventory, net of allowance for obsolete inventory of $227 and $110, respectively 2,037 902
Deferred advertising, current portion 4,595 2,016
Deferred taxes, current portion 413 --
Other current assets 662 483
Total Current Assets 22,167 11,549
Property and equipment, net of accumulated depreciation of $1,384 and $1,021, respectively 1,912 1,041
Deferred advertising, net of current portion 3,927 1,739
Deferred taxes, net of current portion 508 --
Intangible assets, net of accumulated amortization of $3 and $0, respectively 204 --
Other noncurrent assets 226 130
Total Assets $ 28,944 $ 14,459
Liabilities and Stockholders' Equity
Current Liabilities:
Accounts payable $ 5,606 $ 2,089
Accrued liabilities 798 716
Stockholder loan 865 1,515
Convertible notes payable, net of unamortized discount of $26 and $292, respectively 2,493 3,893
Other current liabilities 136 140
Total Current Liabilities 9,898 8,353
Convertible notes payable, net of unamortized discount of $0 and $90, respectively -- 2,447
Deferred tax liability 965 --
Other noncurrent liabilities 176 235
Total Liabilities 11,039 11,035
Stockholders' Equity:
Common stock, $.001 par value, 200,000 shares authorized; 44,636 and 32,462 shares issued, respectively; 44,547 and 32,377 shares outstanding at June 30, 2010 and September 30, 2009, respectively 45 32
Additional paid-in capital 24,274 11,705
Accumulated deficit (6,364) (8,272)
17,955 3,465
Less: Treasury stock, at cost; 89 and 85 shares at June 30, 2010 and September 30, 2009, respectively (50) (41)
Total Stockholders' Equity 17,905 3,424
Total Liabilities and Stockholders' Equity 28,944 14,459
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
For the three and nine months ended June 30, 2010 and 2009
(Unaudited)
(in thousands, except per share amounts)
Three Months Ended
June 30, Nine Months Ended
June 30,
2010 2009 2010 2009
Sales $ 10,619 $ 6,950 $ 29,428 $ 18,119
Cost of Sales 3,677 2,506 10,312 6,425
Gross Profit 6,942 4,444 19,116 11,694
Operating Expenses
Payroll, taxes and benefits 2,569 1,518 7,357 3,857
Advertising 1,336 616 3,255 1,373
Bad debts 1,020 373 2,603 1,861
Depreciation and amortization 179 80 449 214
General and administrative 896 785 2,991 2,445
Total Operating Expenses 6,000 3,372 16,655 9,750
Income from Operations 942 1,072 2,461 1,944
Other Income (Expense)
Interest Expense (150) (267) (621) (812)
Loss on disposal of assets -- -- (2) --
Interest Income 8 3 16 17
Total Other Income (Expense) (142) (264) (607) (795)
Income before Income Taxes 800 808 1,854 1,149
Provision for (benefit from) Income Taxes 2 14 (54) 14
Net Income $ 798 $ 794 $ 1,908 $ 1,135
Basic earnings per share:
Weighted average shares outstanding 41,569 32,133 36,438 32,068
Earnings per share $ 0.02 $ 0.02 $ 0.05 $ 0.04
Diluted earnings per share:
Weighted average shares outstanding 54,783 37,334 51,764 35,990
Earnings per share $ 0.02 $ 0.02 $ 0.04 $ 0.03
Liberator Medical Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
For the nine months ended June 30, 2010 and 2009
(Unaudited)
(in thousands)
2010 2009
Cash flow from operating activities:
Net Income $ 1,908 $ 1,135
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization 3,670 1,458
Equity based compensation 303 365
Provision for doubtful accounts and sales returns 2,759 1,861
Non-cash interest related to convertible notes payable 402 565
Deferred income taxes (21) --
Amortization of non-cash debt issuance costs 23 29
Loss on disposal of assets 2 --
Changes in operating assets and liabilities:
Accounts receivable (5,420) (2,950)
Deferred advertising (7,988) (2,907)
Inventory (1,135) (449)
Other assets (320) 294
Accounts payable 3,516 1,220
Accrued expenses (51) 112
Deferred rent (3) (34)
Net Cash Flow (Used in) Operating Activities (2,355) 699
Cash flow from investing activities:
Purchase of property and equipment (1,324) (369)
Proceeds from the sale of assets 5 --
Purchase of patented technology (207) --
Purchase of certificates of deposit (559) --
Net Cash Flow Used in Investing Activities (2,085) (369)
Cash flow from financing activities:
Proceeds from the sale of common stock 7,000 --
Costs associated with the sale of common stock (407) --
Proceeds from issuance of convertible notes -- 2,500
Costs associated with issuance of convertible notes -- (326)
Proceeds from the exercise of warrants 1,556 --
Proceeds from employee stock purchase plan 102 --
Purchase of treasury stock (9) (41)
Payments of debt and capital lease obligations (711) (148)
Net Cash Flow Provided by Financing Activities 7,531 1,985
Net increase in cash 3,091 2,315
Cash at beginning of period 3,798 1,173
Cash at end of period $ 6,889 $ 3,488
Supplemental disclosure of cash flow information:
Cash paid for interest $ 323 $ 290
Cash paid for income taxes $ 20 $ 21
Supplemental schedule of non-cash investing and financing activities:
Capital expenditures funded by capital lease borrowings $ -- $ 91
Common stock issued for interest expense $ 45 $ 105
Common stock issued for conversion of debt $ 4,102 $ 85
Contact:
Wall Street Resources, Inc.Individual Investor Relations ContactGerald Kieft772-219-7525LiberatorIR@wallstreetresources.nethttp://www.wallstreetresources.netLittlebanc Advisors, LLCInstitutional Investor ContactLyn Davis561-948-3005ld@littlebanc.comwww.littlebanc.com
Their making very good money. I'm holding tight.
Talking to myself again.
Yawn. Really quiet here.
I saw this morning that the outstanding shares went from 39 million to 44 million. Should be a good thing more shares will be able to be traded during the day. We have a reat company here just have to be patient. Good luck everyone.
I agree it looks good the price is at fair value right now IMO...although I have another Med stock in the same PPS range I'm checking out that is also having incredible growth might have to play them both.
Another good quarter in the books. They are going for growth right now i think they do not care to much about huge profits at this point. Next quarter should be really nice I'm guessing around 12.5 million with a million profit. Do not sell this stock we have a winner just have to wait a few more years. Good luck.
Nice thing is now that have lots of cash on hand shouldn't be to much of a need to dilute much with the $6million on hand
I don't disagree. As long as the top line is still growing, a pause in bottom-line growth is not necessarily a problem. The strategy of trying to get big as quickly as possible makes sense to me.
Yep saw that but there was huge increase in advertising as well that didn't help,but sales are growing so at some point in time the advertising can slow down when the repeat customers are coming in eventually it will lead to higher Net Income
Net income flat though, so the stock didn't move. Still, good progress.
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
403
|
Created
|
06/22/07
|
Type
|
Free
|
Moderators |
Investment Highlights:
Liberator Medical Holdings , Inc.
2979 SE Gran Park Way
Stuart, FL 34997
United States
Phone: 772-287-2414
Fax: 772-286-7881
Website: http://www.liberatormedical.com or http://www.liberatordirect.com/
OTCBB: LBMH.OB
Overview
Liberator Medical Supply, Inc. (“LMS”), a wholly-owned subsidiary of the Company, is a federally licensed, direct-to-consumer, provider of Medicare Part B Benefits focused on providing medical supplies in a retail environment and via the Internet in the United States. LMS distributes a full range of medical products which address the healthcare needs of our customers.
We market our products directly to consumers primarily through targeted media and direct response television advertising. Our customer service representatives are specifically trained to communicate with Medicare-eligible beneficiaries. Our operating platforms enable us to collect and process required documents from physicians and customers, bill and collect amounts due from Medicare and/or other government agencies and/or third party payors and/or customers.
Executive Summary
Our emphasis continues to be on top line sales growth while controlling our costs in order to sustain profitable growth. For the third quarter of fiscal year 2010, our sales increased by 53%, to $10.6 million, compared with the third quarter of fiscal year 2009. For the nine months ended June 30, 2010, our sales increased by 62%, to $29.4 million, compared with the nine months ended June 30, 2009.
We have been able to significantly grow our sales over the last three fiscal years through the downturn in the U.S. economy. Our growth has been driven by our direct response marketing campaign, primarily through television ads at remnant (discounted) rates. Based on information from our media buying agents, we believe that demand for television time slots within the direct response advertising market has increased over the last nine months, creating a more competitive environment within this medium. Although customer acquisition costs remain at acceptable levels, during the third quarter of fiscal year 2010 we increased our spending significantly in alternative media channels and plan to continue those efforts.
Over the last nine months, we have invested heavily in our infrastructure by adding both personnel and facilities, so that we continue to remain capable of supporting a much higher sales volume. We currently have approximately 50% of each of our facilities available for future growth. We have chosen to build our infrastructure ahead of our advertising spend, which helps us achieve compliance on many fronts and maintain the quality of our customer service. Our cost structure continues to remain flexible enough to adapt to changing market conditions. We can pulse our advertising spend and the expansion of our workforce relatively quickly based on the results of our marketing programs. While our sales have increased during the last nine months, we have been able to decrease our general and administrative costs as a percentage of sales.
We believe we are well positioned to continue to grow our sales and improve profitability over the long term.
Management Team:
http://www.liberatormedical.com/investor-relations.aspx
CEO: Mark Libratore
Outstanding Shares: 44.6 Million
Float: 6.96Million
======================================================================================================================================================================================================================================
Revenue Per Quarter
September 30th, 2012 $16,516,000
December 31st, 2012 $17,551,000
March 31st, 2013 $16,734,000
June 30th, 2013 $17,491,000
Annual Revenue
September 30th, 2010 $40,919,000
September 30th, 2011 $52,698,000
September 30th, 2012 $60,943,000
September 30th, 2013 $69,111,000
======================================================================================================================================================================================================================================
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |